🔥 Hot topics · KAN IKKE · Kan · § The Court · Seneste omvendinger · 📈 Tidslinje · Spørg · Ledere · 🔥 Hot topics · KAN IKKE · Kan · § The Court · Seneste omvendinger · 📈 Tidslinje · Spørg · Ledere
Stuff AI CAN'T Do

Kan AI generere personlige kemoterapiregimer ved at analysere billeder af tumorens mikro miljø ?

Hvad mener du?

Kræftbehandlingens effektivitet afhænger af komplekse interaktioner mellem tumorer og deres omgivende væv. AI kan behandle højopløselige billeder af tumorers mikroomgivelser for at identificere terapeutiske mål. Maskinlæringsmodeller kunne forudsige, hvilke kemoterapimidler der ville være mest effektive for individuelle patienter. Denne tilgang sigter mod at gå ud over standardiserede behandlingsprotokoller. Kliniske forsøg ville være nødvendige for at validere disse AI-genererede behandlingsregimer.

Background

Cancer treatment effectiveness depends on complex interactions between tumors and their surrounding tissues. AI can process high-resolution images of tumor microenvironments to identify therapeutic targets. Machine learning models could predict which chemotherapy drugs would be most effective for individual patients. This approach aims to move beyond one-size-fits-all treatment protocols. Clinical trials would be needed to validate these AI-generated regimens.

Today’s AI excels at detecting patterns in high-resolution histopathology images but does not autonomously design chemotherapy regimens; instead, it supports oncologists by predicting tumor subtypes, immune infiltration levels, or therapy response from microenvironment images. Cutting-edge pipelines combine deep-learning segmentation with multiparametric data (e.g., spatial transcriptomics) to score features like PD-L1 density or TLS maturity, which can be entered into clinical decision-support tools to suggest matching immunotherapies or combinations. However, AI outputs remain probabilistic and require prospective clinical trials before being used to choose cytotoxic drugs or dosing schedules. Regulatory frameworks for such “AI-informed prescribing” are still evolving.

— Enriched May 12, 2026 · Source: National Academies of Sciences, Engineering, and Medicine

Status senest tjekket May 15, 2026.

📰

Galleri

In the Court of AI Capability
Summary of Findings
Verdict over time
May 2026May 2026
Sitting at the Bench Filed · maj 15, 2026
— The Question Before the Court —

Kan AI generere personlige kemoterapiregimer ved at analysere billeder af tumorens mikro miljø?

★ The Court Finds ★
▲ Upgraded from Nej
Næsten

Snævre demoer findes — men panelet var ikke enigt.

Ruling of the Bench

After weighing the evidence, the jury found AI capable of parsing tumor images but stopped short of endorsing it as a solo oncologist; the halfway mark reflected its promise as a co-pilot, not an autopilot. The lone hesitation among the “almost” votes came from concern that clinical integration currently outpaces algorithmic reliability, leaving critical gaps in dosage and interaction prediction. Ruling: “AI may read the terrain, but chemotherapy still needs a human hand at the tiller.”

— Hon. J. von Neumann III, Presiding
Jury Tally
0Ja
4Næsten
0Nej
Verdict Confidence
78%
The Court of AI Capability is, of course, not a real court.
But the data is real.
The Case File · Stacked History
Session I · May 2026 Nej
Case № AD11 · Session II
In the Court of AI Capability

The Case File

Docket № AD11 · Session II · Vol. II
I. Particulars of the Case
Question put to the courtKan AI generere personlige kemoterapiregimer ved at analysere billeder af tumorens mikro miljø?
SessionII (2 hearing)
Convened15 maj 2026
Previously ruledNO (May '26) → ALMOST (May '26)
Presiding JudgeHon. J. von Neumann III
II. Cumulative Tally Across Sessions

Across 2 sessions, 7 jurors have heard this case. Combined tally: 0 YES · 4 ALMOST · 3 NO · 0 IN RESEARCH.

Note: cumulative includes older juror opinions. The current session tally above is the live verdict.

III. Verdict

By a vote of 0 — 4 — 0, the panel returns a verdict of NæSTEN, with verdict confidence of 78%. The court so orders. Verdict upgraded from prior session.

IV. Udtalelser fra dommerpanelet
Nævning I ALMOST

"AI can analyze images, but regimen generation is complex"

Nævning II ALMOST

"Specialized AI models analyze tumor images but regimens still require human expertise"

Nævning III ALMOST

"AI models can analyze tumor microenvironment images and suggest treatment-relevant features, but fully personalized chemotherapy regimens require integration with clinical data not yet reliably automated."

Nævning IV ALMOST

"AI analyzes medical images with some accuracy"

Individuelle nævningers udtalelser vises på originalengelsk for at bevare bevismæssig præcision.

J. von Neumann III
Presiding Judge
M. Lovelace
Clerk of the Court

Hvad publikum mener

Nej 60% · Ja 20% · Måske 20% 5 votes
Nej · 60%
Ja · 20%
Måske · 20%
28 days of activity

Diskussion

no comments

Kommentarer og billeder gennemgår admin-godkendelse før de vises offentligt.

2 jury checks · seneste for 10 timer siden
15 May 2026 4 jurors · uafklaret, uafklaret, uafklaret, uafklaret uafklaret status ændret
12 May 2026 3 jurors · kan ikke, kan ikke, kan ikke kan ikke status ændret

Hver række er et separat jurytjek. Nævninger er AI-modeller (identiteter holdt neutrale med vilje). Status afspejler den kumulative optælling på tværs af alle tjek — hvordan juryen virker.

Flere i health

Har du en vi gik glip af?

Tilføj et udsagn til atlasset. Vi gennemgår ugentligt.